These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1576625

  • 1. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Ruoff GE.
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [Abstract] [Full Text] [Related]

  • 2. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML, Jacobson KD, Guerra FJ, Therasse DG, Farlow D.
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [Abstract] [Full Text] [Related]

  • 3. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
    Iravani A.
    Clin Ther; 1992; 14(1):54-63. PubMed ID: 1576626
    [Abstract] [Full Text] [Related]

  • 4. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Jacobson KD, Guerra FJ.
    Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
    [Abstract] [Full Text] [Related]

  • 5. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
    Hyslop DL, Jacobson K, Guerra FJ.
    Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
    [Abstract] [Full Text] [Related]

  • 6. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
    Paster RZ, McAdoo MA, Keyserling CH, Nemeth MA, Tack KJ, Griffin TJ.
    Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
    [Abstract] [Full Text] [Related]

  • 7. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J, Ruoff GE, Jacobson KD.
    Am J Med; 1992 Jun 22; 92(6A):80S-85S. PubMed ID: 1621751
    [Abstract] [Full Text] [Related]

  • 8. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
    Hyslop DL, Bischoff W.
    Am J Med; 1992 Jun 22; 92(6A):86S-94S. PubMed ID: 1621752
    [Abstract] [Full Text] [Related]

  • 9. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A, Longest KA, Senetar JE, Dere WH.
    Postgrad Med J; 1992 Jun 22; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [Abstract] [Full Text] [Related]

  • 10. Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
    Iravani A.
    Antimicrob Agents Chemother; 1991 Apr 22; 35(4):750-2. PubMed ID: 2069382
    [Abstract] [Full Text] [Related]

  • 11. Oral cefaclor for treatment of bronchitis--a comparative double-blind study versus amoxycillin.
    Beumer HM, Veldkamp J.
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar 22; 20(3):113-7. PubMed ID: 7068283
    [Abstract] [Full Text] [Related]

  • 12. [Cephalosporin treatment of maxillary sinusitis].
    Köhler W, Schenk P.
    Laryngorhinootologie; 1995 Jun 22; 74(6):355-60. PubMed ID: 7662079
    [Abstract] [Full Text] [Related]

  • 13. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis.
    Hurst DJ.
    Clin Ther; 1984 Jun 22; 6(2):163-9. PubMed ID: 6231104
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ.
    Clin Ther; 1999 Jan 22; 21(1):172-88. PubMed ID: 10090434
    [Abstract] [Full Text] [Related]

  • 15. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
    Bandak SI, Bolzon LD, Turnak MR, Johns D, Henle SK, Allen BS.
    Int J Clin Pract; 1999 Dec 22; 53(8):578-83. PubMed ID: 10692750
    [Abstract] [Full Text] [Related]

  • 16. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
    Zeckel ML.
    Am J Med; 1992 Jun 22; 92(6A):58S-64S. PubMed ID: 1621746
    [Abstract] [Full Text] [Related]

  • 17. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
    Fong IW, Laforge J, Dubois J, Small D, Grossman R, Zakhari R.
    Clin Invest Med; 1995 Apr 22; 18(2):131-8. PubMed ID: 7788958
    [Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov 22; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 19. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P, Dobryniewska M, Busman T, Notario G.
    Curr Med Res Opin; 2003 Nov 22; 19(5):411-20. PubMed ID: 13678478
    [Abstract] [Full Text] [Related]

  • 20. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis.
    Grossman RF.
    Postgrad Med J; 1992 Nov 22; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.